Your browser doesn't support javascript.
loading
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.
Annala, Matti; Struss, Werner J; Warner, Evan W; Beja, Kevin; Vandekerkhove, Gillian; Wong, Amanda; Khalaf, Daniel; Seppälä, Irma-Liisa; So, Alan; Lo, Gregory; Aggarwal, Rahul; Small, Eric J; Nykter, Matti; Gleave, Martin E; Chi, Kim N; Wyatt, Alexander W.
Affiliation
  • Annala M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland.
  • Struss WJ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada.
  • Warner EW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada.
  • Beja K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada.
  • Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada.
  • Wong A; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada.
  • Khalaf D; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada.
  • Seppälä IL; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland.
  • So A; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada.
  • Lo G; RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada.
  • Aggarwal R; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
  • Small EJ; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
  • Nykter M; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland.
  • Gleave ME; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada.
  • Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada.
  • Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: awyatt@prostatecentre.com.
Eur Urol ; 72(1): 34-42, 2017 07.
Article in En | MEDLINE | ID: mdl-28259476
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Germ-Line Mutation / Antineoplastic Agents, Hormonal / Loss of Heterozygosity / DNA Repair / Prostatic Neoplasms, Castration-Resistant / Androgen Antagonists Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2017 Document type: Article Affiliation country: Finland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Germ-Line Mutation / Antineoplastic Agents, Hormonal / Loss of Heterozygosity / DNA Repair / Prostatic Neoplasms, Castration-Resistant / Androgen Antagonists Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2017 Document type: Article Affiliation country: Finland